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(57) ABSTRACT 
A 3D microelectrode device includes a flexible substrate con-
taining poly-dimethyl siloxane (PDMS). The device may be 
fabricated in a miniature form factor suitable for attachment 
to a small organ such as a lateral gastrocnemius muscle of a 
live rat. In addition to providing a miniaturized, conformable 
attachment, the device provides an anchoring action via one 
or more microelectrodes, each having an insertable tip par-
ticularly shaped to provide the anchoring action. Further-
more, a base portion of each of the microelectrodes is embed-
ded inside conductive poly-dimethyl siloxane ( cPDMS). The 
cPDMS is contained in a pad that is coupled to a conductive 
track embedded in the flexible substrate. Embedding of the 
base portion inside the cPDMS material not only allows the 
microelectrode to bend in various directions, but also pro-
vides good electrical conductivity while eliminating the need 
for attachment processes using solder or epoxy adhesives. 
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3D MICROELECTRODE DEVICE FOR LIVE 
TISSUE APPLICATIONS 
CROSS-REFERENCE 
This application claims the benefit of priority to U.S. Pro-
visional Application Ser. No. 61/660,876, filed Jun. 18, 2012, 
which is incorporated herein by reference in its entirety and 
for all purposes 
2 
the microelectrodes from penetrating the outer layer of organ 
125. Furthermore, it can be understood that the projecting 
portion of device 110 may make undesirable contact with 
adjacent organs (not shown) and may potentially cause dam-
age to these adjacent organs. 
The disadvantages described above with reference to prior 
art microelectrode device 110 are alleviated to some extent by 
a different prior art microelectrode device 130 that is dis-
closed in a third prior art reference document titled "PDMS-
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH OR DEVELOPMENT 
10 Based Stretchable Multi-Electrode and Chemotrode Array 
for Epidural and Subdural Neuronal Recording, Electrical 
Stimulation and Drug Delivery" (International Publication 
Number WO 2011/157714 Al). 
As shown in FIG. 3, device 130 not only incorporates a This invention was made with government support under 
grant NS071894-01 awarded by the National Institute of 
Health. The government has certain rights in the invention. 
BACKGROUND 
15 flexible substrate that conforms to a surface layer of organ 
125, but also includes certain features that are allegedly 
advantageous for in-vivo applications wherein placement of 
the microelectrodes to the proximity of an organ, such as the 
spinal cord of a rat, is desirable. As described in the third prior 
20 art reference document, the non-penetrating nature of the 
microelectrodes makes the implantation less invasive and less 
traumatic-thereby teaching away from the use of penetrat-
ing microelectrodes such as those disclosed in the first and 
Approximately 62 million people in this world are esti-
mated to have some form of paralysis, and approximately 10 
million people are estimated to have received an amputation. 
One of the techniques utilized to afford greater mobility to 
amputees is myoelectric prosthesis. Myoelectric prosthesis 
typically involves the measurement of electrical activity in a 25 
contracting muscle located close to the site of the paralysis/ 
amputation and using the measurement to provide suitable 
electrical stimuli to the paralyzed muscle or to residual func-
tioning muscle. In essence, myoelectric prosthesis enables 
individuals to control a paralyzed muscle (or robotic pros-
thetics) through a residual functioning muscle. Unfortu-
nately, the degree of motor function returned via myoelectric 
prosthesis is limited, largely due to the prosthetic's inability 
second prior art reference documents. 
More particularly, device 130 is placed such that surround-
ing tissue material ( dura matter for example) located above 
and below device 130, provides an anchoring action to keep 
device 130 in place without damaging the spinal cord. The 
lack of an intrinsic anchoring element in device 130 makes it 
30 difficult or impossible to use device 130 upon certain tissue 
surfaces where surrounding tissue or other structures are 
unavailable to hold device 130 in place. 
Furthermore, the size and shape of the spinal cord neces-
sitates that device 130 have a relatively large and elongated to extract sufficient information from a working muscle or to 
adequately control paralyzed muscle via electrical stimula-
tion. Furthermore, existing devices and techniques used for 
performing myoelectric prosthesis suffer from various limi-
tations. 
To elaborate upon a first limitation, attention is drawn to a 
first prior art reference document titled "Microelectrodes with 
Three-dimensional Structures for Improved Neural Interfac-
ing," by S. Metz et al, and further to a second prior art 
reference document titled "A Three-Dimensional Multi-elec-
trode Array for Multi-site Stimulation and Recording in Acute 
Brain Slices," by Marc Olive Heuschkel et. al. 
35 shape (together with relatively large dimensions for pads, 
tracks, holes etc.). In this context, it may be pertinent to draw 
attention to FIGS. 11 and 12 of the third prior art reference 
document and the associated description, which discloses a 
conductive track width of 150 µm, minimum distance 
40 between adjacent tracks if 150 µm, diameter of each micro-
electrode is 350 µm, and holes of 350 µm diameter. While 
such dimensions may be acceptable for mounting on to rela-
tively large organs, these dimensions are not suitable for use 
The teachings in these two prior art reference documents 
may be summarized using FIG. 1 that is shown herein in this 
disclosure. 
45 
Prior art microelectrode device 110, which is coupled to an 
electrical stimulus transmitter/response signal receiver 105, 50 
contains a number of microelectrodes that are mounted on a 
rigid glass substrate and are shaped for penetrating a tissue 
slice 115. More particularly, the microelectrodes are pyra-
mid-shaped microelectrodes that are allegedly advantageous 
for penetrating dead cell layer 116 and getting closer to active 55 
cells located below dead cell layer 116. 
While microelectrode device 110 does provide certain 
advantages for in-vitro applications, the rigid nature of the 
glass substrate and the size of the device (for example, a 60 
microelectrode device is shown to have a size of 5x5 cm2 ) 60 
make this prior art device unsuitable for many in-vivo appli-
cations, especially when it is desired to implant such a device 
upon a small-sized live organ, live muscle or live tissue. 
This aspect is illustrated in FIG. 2. When microelectrode 
device 110 is implanted upon organ 125, which may be an 65 
internal organ of a rat for example, the rigid nature of the 
substrate and the size of the device 110 permit only a few of 
when the organ is very small in size. 
In view of the above-mentioned remarks, it would be desir-
able to make certain improvements to existing microelectrode 
devices. 
SUMMARY 
According to a first aspect of the disclosure, a device that 
includes a flexible substrate, a track and a microelectrode is 
provided. The flexible substrate is configured to provide 
three-dimensional conformance with a live tissue surface sus-
ceptible to movement. The track, which contains conductive 
poly-dimethyl siloxane (cPDMS) material, is embedded in 
the flexible substrate for conducting an electrical signal. The 
microelectrode has a base portion, a longitudinal portion, and 
an insertable tip. The base portion has a shape configured for 
anchoring the base portion in the cPDMS material and the 
insertable tip has a leading portion configured for penetrating 
the tissue surface and making contact with a muscle located 
below the tissue surface. 
According to a second aspect of the disclosure, an implant-
able device that includes a flexible substrate, a plurality of 
signal-conducting tracks, and a plurality of microelectrodes 
is provided. The flexible substrate is configured to provide 
US 9,248,273 B2 
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three-dimensional conformance with an in-vivo surface that 
is susceptible to flexing. The plurality of signal-conducting 
tracks is embedded in the flexible substrate, each of the plu-
rality of tracks comprising conductive poly-dimethyl silox-
ane (cPDMS) material. The plurality of microelectrodes is 
arranged in an array configuration, each of the plurality of 
microelectrodes comprising a base portion and a protruding 
portion. The base portion has a shape configured for anchor-
ing the microelectrode in the cPDMS material, and the pro-
truding portion has a shape configured for penetrating the 10 
in-vivo surface and for anchoring the implantable device 
upon the in-vivo surface 
According to a third aspect of the disclosure, a method of 
manufacturing a 3D microelectrode device includes the fol-
lowing: applying a layer of SU-8 upon a silicon substrate; 15 
using lithography to define a layout pattern in the SU-8 layer; 
developing the SU-8 layer, the developing directed at creating 
4 
FIG. 1 shows a first prior art microelectrode device used in 
an in-vitro application. 
FIG. 2 shows the first prior art microelectrode device used 
in an in-vivo application. 
FIG. 3 shows a second prior art microelectrode device used 
in an in-vivo application. 
FIG. 4 shows an exemplary in-vivo application of a 3D 
microelectrode device in accordance with an embodiment of 
the present invention. 
FIG. 5 shows an exemplary embodiment of a 3D micro-
electrode device in accordance with an embodiment of the 
present invention. 
FIG. 6 shows a first exemplary insertable tip that is a part of 
a 3D microelectrode device in accordance with an embodi-
ment of the present invention. 
FIG. 7 shows a second exemplary insertable tip that is a 
part of a 3D microelectrode device in accordance with an 
embodiment of the present invention. 
FIG. 8 shows a third exemplary insertable tip that is a part 
of a 3D microelectrode device in accordance with an embodi-
ment of the present invention. 
FIG. 9A shows a microelectrode as viewed after comple-
tion of a first step in an example manufacturing procedure of 
the microelectrode in accordance with an embodiment of the 
25 present invention. 
at least 1) a first indentation corresponding to a track in the 
layout pattern and 2) a second indentation corresponding to a 
pad in the layout pattern; applying a layer of metal upon the 20 
developed SU-8 layer; applying a layer of conductive poly-
dimethyl siloxane (cPDMS) material on top of the layer of 
metal such that the cPDMS material fills the first and second 
indentations; placing a 3D microelectrode in an upright posi-
tion in the second indentation, a base portion of the 3D micro-
electrode operative to anchoring the microelectrode in the 
cPDMS material; curing the assembly for encapsulating at 
least the base portion of the 3 D microelectrode in the cPD MS 
material; applying a layer of poly-dimethyl siloxane (PDMS) 
material on top of the cured cPDMS material; and removing 30 
the silicon substrate by demolding, whereby the remaining 
portion that includes the cPDMS material, the 3D microelec-
trode, and the PDMS material constitutes at least a part of the 
3D microelectrode device. 
FIG. 9B shows the microelectrode of FIG. 9A as viewed 
after completion of a second step in the example manufactur-
ing procedure of the microelectrode in accordance with an 
embodiment of the present invention. 
FIG.10 shows an exemplary stainless steel microneedle in 
accordance with an embodiment of the present invention. 
FIG. 11 shows a 3D microelectrode device configured for 
coupling to an extender assembly using a lamination process 
in accordance with an embodiment of the present invention. 
FIG. 12 shows a lamination apparatus for executing a lami-
nation process in accordance with an embodiment of the 
present invention. 
FIG. 13 illustrates an SU-8 based procedure for fabricating 
a 3D microelectrode device in accordance with an embodi-
According to a fourth aspect of the disclosure, a method of 35 
manufacturing a microelectrode apparatus, includes the fol-
lowing: applying a layer of photoresist upon a silicon sub-
strate; using photo lithography to define a layout pattern in the 
photoresist layer; developing the photoresist layer; etching 
the silicon substrate for creating at least 1) a first indentation 
corresponding to a track and 2) a second indentation corre-
sponding to a pad in the layout pattern; applying a layer of 
metal upon the developed photo-resist layer; applying a layer 
40 ment of the present invention. 
FIG.14 illustrates a silicon based procedure for fabricating 
a 3D microelectrode device in accordance with an embodi-
ment of the present invention. 
of conductive poly-dimethyl siloxane ( cPDMS) material on 
top of the layerofmetal such thatthe cPDMS material fills the 45 
first and second indentations; placing a microelectrode in an 
upright position in the second indentation, a base portion of 
the microelectrode operative to anchoring the microelectrode 
DETAILED DESCRIPTION 
Throughout this description, embodiments and variations 
are described for the purpose of illustrating uses and imple-
mentations of the inventive concept. The illustrative descrip-
tion should be understood as presenting examples of the 
inventive concept, rather than as limiting the scope of the 
concept as disclosed herein. For example, it will be under-
stood that terminology such as upper, lower, top, bottom, 
pins, pads, and tracks are used herein as a matter of conve-
in the cPDMS material; curing the assembly for encapsulat-
ing the microelectrode in the cPDMS material; applying a 50 
layer of poly-dimethyl siloxane (PDMS) material on top of 
the cured cPDMS material; and removing the silicon sub-
strate by demolding, the remaining portion that includes the 
cPDMS material, the microelectrode, and the PDMS material 
constituting at least a part of the microelectrode apparatus. 55 nience for description purposes and should not be interpreted 
in a limiting mamier. As one can appreciate, the word "upper" 
used in a first context may be referred to as "lower" in a 
different context, and consequently, such terms should be 
interpreted solely to understand the invention rather than to 
Further aspects of the disclosure are shown in the specifi-
cation, drawings and claims below. 
BRIEF DESCRIPTION OF THE DRAWINGS 
Many aspects of the invention can be better understood 
with reference to the following drawings. The components in 
the drawings are not necessarily to scale. Instead, emphasis is 
placed upon clearly illustrating the principles of the inven-
tion. Moreover, in the drawings, like reference numerals des-
ignate corresponding parts, or descriptively similar parts, 
throughout the several views and embodiments. 
60 circumvent it, for example, by flipping an object upside down, 
or mirroring the object. 
It must also be understood that the word "example" as used 
herein (in whatever context) is intended to be non-exclusion-
ary and non-limiting in nature. Specifically, the word "exem-
65 plary" when used indicates one among several examples, and 
it must be understood that no special emphasis is intended or 
suggested for that particular example. A person of ordinary 
US 9,248,273 B2 
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skill in the art will understand the principles described herein 
and recognize that these principles can be applied to a wide 
variety of devices and applications. 
The various embodiments disclosed here in accordance 
with the invention generally describe a 3D microelectrode 
device that may be used for live tissue applications. While live 
tissue is typically associated with in-vivo applications, it must 
be understood that the various embodiments are not limited to 
in-vivo applications and may be used for in-vitro applications 
as well. 
Furthermore, while reference is made herein to materials 
generically known in the art as poly-dimethyl siloxane 
(PDMS) and conductive poly-dimethyl siloxane ( cPDMS), it 
must be understood that the various embodiments disclosed 
herein may incorporate a specific formulation, composition, 
manufacture, and application of PDMS and cPDMS. These 
aspects will be described below in further detail. 
6 
elongated layout format for the microelectrodes and/or the 
substrate may be used for an organ having a longitudinal 
shape, and an irregularly shaped layout format for the micro-
electrodes and/or the substrate may be used for an organ 
having and irregular shape and/or an irregular surface con-
tour. In one example implementation, the microelectrodes are 
arranged as a 2x2 array occupying an area of about 2 mm2 , 
with an inter-electrode spacing of about 200 µm. 
In the embodiment shown in FIG. 5, 3D microelectrode 
10 device 500 includes a flexible substrate 505 upon which is 
located an array of microelectrodes. Substrate 505 is a flex-
ible substrate containing PDMS and allows 3D microelec-
trode device 500 to be conformably placed upon live muscle/ 
tissue. For purposes of describing certain details about the 
15 array of microelectrodes, a single microelectrode 510 will be 
used hereon as a matter of convenience. However, it will be 
understood that the description is equally applicable to other 
similar microelectrodes and elements of 3D microelectrode 
device 500 as well. 
PDMS has many desirable characteristics such as being 
bio-compatible, being compatible for large area microfabri-
cation, and possessing a Young's modulus at least three orders 20 
of magnitude lower than materials such as silicon and poly-
imide that are used in various prior art intramuscular micro-
electrode arrays. Due to the Young's modulus property alone, 
PDMS has the potential to cause less scar-tissue encapsula-
tion and may be applied across a large interfacial area. 
Microelectrode 510, which may be formed of a material 
that is either a good conductor of electrical signals (for 
example, a metal) or of a material that is at least a partially 
good conductorof electrical signals (for example, a polymer), 
is anchored in a pad 515 that is formed of conductive poly-
25 dimethyl siloxane (cPDMS) material. 
Associated with PDMS is a compound referred to as 
cPDMS, which is manufactured by dispersing conductive 
metal flakes in a PDMS polymer. When cPDMS is used in the 
form of electrically conductive tracks or pads, the cPDMS 
conductive tracks and pads maintain a high conductivity/low 30 
resistance characteristic even under a relatively high degree 
When 3D microelectrode device 500 is placed in operative 
condition, electrical signals coupled into microelectrode 510 
(from tissue/muscle in which microelectrode 510 is embed-
ded) are transferred from microelectrode 510 directly into the 
cPDMS material contained in pad 515 and from thereon, into 
conductive track 520 (which also contains cPDMS material) 
of tensile strain. 
Attention is now drawn to FIG. 4, which shows an example 
embodiment of a 3D microelectrode device 400 in accor-
dance with an embodiment of the present invention. 3D 
microelectrode device 400, which may be coupled to an elec-
trical stimulus transmitter and/or response signal receiver 
405, is shown conformably attached to a small internal organ 
410, such as a lateral gastrocnemius muscle of a rat (thereby 
illustrating the miniature size of an embodiment of the 
present invention). 
In addition to providing a miniaturized, conformable 
attachment, 3D microelectrode device 400 also provides an 
anchoring action via a microelectrode array 415 containing a 
number of microelectrodes each having a shape that is spe-
cifically selected to provide the anchoring action. This aspect 
will be described below in further detail. 
and to a cPDMS pad 525 that is one pad in a set of cPDMS 
pads 530. 
Prior art techniques of attaching a microelectrode to a 
35 substrate (even a flexible substrate) include soldering the 
microelectrode to a metal pad, or attaching the microelec-
trode to the pad using an epoxy compound. In contrast, and in 
accordance with an embodiment of the present invention, a 
base portion of microelectrode 510 is shaped in a manner that 
40 accommodates anchoring of microelectrode 510 directly in 
the cPDMS material contained in pad 515 without requiring 
solder or epoxy compounds. 
The cPDMS material contained in pad 515 not only 
anchors microelectrode 510, but has a Young's Modulus 
45 index that permits the base portion ofmicroelectrode 510 to 
pivot in various directions, thereby allowing microelectrode 
510 to bend in accordance with the contours of a muscle/ 
tissue surface and/or in order to accommodate movement in a 
live muscle/tissue surface. Movement in the muscle/tissue 
A base portion of each of the microelectrodes inmicroelec-
trode array 415 is embedded inside conductive poly-dimethyl 
siloxane ( cPDMS) thereby providing good electrical conduc- 50 
tivity as well as bendability-two parameters that are advan-
tageous for mounting 3D microelectrode device 400 upon a 
live tissue surface susceptible to movement. 
surface may be further accommodated by selecting a suitable 
microelectrode 510 having a flexible property such as a poly-
mer microelectrode, for example. 
Similar to pad 515, conductive track 520 also contains 
cPDMS and accommodates 3D flexing and bending of 3D 
55 microelectrode device 500 while providing good conductiv-
ity to electrical signals. 
These features, as well as other advantageous features, will 
be described below using additional figures. 
Towards this end, attention is drawn to FIG. 5, which shows 
a few constituent elements of a 3D microelectrode device 500 
in accordance with an embodiment of the present invention. 
Though this embodiment includes a number of microelec-
trodes arranged in an array layout format, it will be under-
stood that in other embodiments, a single microelectrode may 
be used, or two or more microelectrodes may be arranged in 
a non-array (or array) layout format. Furthermore, the layout 
formats of the microelectrodes as well as the form factor and 
shape of the substrate upon which the microelectrodes are 
located may be selected on the basis of the organ upon which 
the 3D microelectrode device is to be placed. For example, an 
FIG. 6 shows a first example embodiment of a microelec-
trode 510 in accordance with an embodiment of the present 
invention. Microelectrode 510, which may be a microma-
60 chined or micro-stamped part fabricated from a sheet of 
metal, includes an insertable tip 610, a longitudinal portion 
615, and a base portion 620. Insertable tip 610 is not only 
shaped to penetrate muscle/tissue but also to provide an 
anchoring action after penetration. More particularly, a lead-
65 ing portion 611 has a pointed shape that penetrates muscle/ 
tissue and a trailing portion 612 that hinders withdrawal of 
microelectrode 510 from muscle/tissue. 
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vide additional anchoring when microelectrode 510 is 
inserted into muscle and/or tissue. 
Microelectrode 510 also includes a base portion 820 that 
may be provided in different shapes. In addition to the shape 
shown in FIG. 8, adifferent shape is shown in FIGS. 9 andlO, 
which will now be used to describe one example of a manu-
facturing process for manufacturing microelectrode 510. 
In this example embodiment, insertable tip 610 has a dia-
mond-shaped cross-sectional profile with leading portion 611 
constituting two sides of the diamond-shaped profile. Trailing 
portion 612 constitutes two other sides of the diamond-
shaped profile. Angular displacement 613 may be selected on 
the basis of a desired "pointiness" for penetration purposes 
into various types of muscle and/or tissue, while angular 
displacement 614 may be selected on the basis of a desired 
level of anchoring in various types of muscle and/or tissue 
without causing excessive damage when microelectrode 510 
is withdrawn from the muscle/tissue. 
FIG. 9A shows a microelectrode 510 viewed after comple-
tion of a first step in an example manufacturing procedure of 
10 
microelectrode 510 in accordance with an embodiment of the 
Longitudinal portion 615 has a length that is selected on the 
basis of a desired protrusion distance from a top surface of 
flexible substrate 505 (shown, for example, in FIG. 5). The 15 
protrusion distance may be selected on the basis of a desired 
penetration depth into tissue or muscle. Base portion 620 is 
anchored in the cPDMS material contained in pad 515 
(shown, for example, in FIG. 5). 
FIG. 7 shows a second example embodiment of a micro- 20 
electrode 510 in accordance with the invention. In contrast to 
the diamond-shaped profile of insertable tip 610 described 
above, in this second embodiment, insertable tip 710 is an 
arrowhead tip having a substantially triangular shape. The 
surface area of insertable tip 710 may be selected to provide 25 
a desired amount of contact between microelectrode 510 and 
various types of muscle and/or tissue. Correspondingly, the 
overall dimensions of microelectrode 510 may be tailored on 
the basis of penetration parameters and contact parameters 
associated with various types of muscle and/or tissue, and/or 30 
on the basis of the size and shape of the muscle and/or tissue. 
The leading portion 711 of insertable tip 710 has a suitable 
angular displacement 713 between two sides of the triangle. 
Angular displacement 713 may be selected on the basis of a 
desired level of penetrability and/or ease of penetrability into 35 
various types of muscle and/or tissue. 
In contrast to the shape of trailing portion 612 described 
above, the trailing portion 712 of insertable tip 710 has a 
substantially straight configuration. More particularly, trail-
ing portion 712 is oriented substantially parallel to a tissue 40 
surface when leading portion 711 has penetrated the tissue 
surface. 
FIG. 8 shows a third example embodiment of a microelec-
trode 510 in accordance with the invention. Similar to insert-
able tip 710, which is an arrowhead tip having a substantially 45 
triangular shape, insertable tip 810 also is an arrowhead tip 
having a substantially triangular shape. However, the angular 
displacements in insertable tip 810 are different than those in 
insertable tip 710. 
Angular displacement 813 may be selected on the basis of 50 
a desired level of penetrability and/or ease of penetrability 
into various types of muscle and/or tissue. 
In contrast to the shape of trailing portion 712 described 
above, the trailing portion 812 has an angular orientation that 
may be defined on the basis of angular displacement 814. 55 
Angular displacement 814 may be selected on the basis of a 
desired level of anchoring in various types of muscle and/or 
tissue without causing excessive damage when microelec-
trode 510 is withdrawn from the muscle/tissue. 
It can be understood that angular displacement 814 is ori- 60 
ented in an opposing direction to angular displacement 614 
(described above with reference to the embodiment shown in 
FIG. 6), thereby providing a higher level of anchoring than 
angular displacement 614. 
However, angular displacement 814 is oriented in the same 65 
direction as angular displacement 813. The sharp tips at the 
vertices of leading portion 811 and trailing portion 812 pro-
present invention. In this example, microelectrode 510 has a 
base portion 910 that includes a major portion 912 that is 
substantially square or rectangular in shape (with rounded 
corners) and a pair of ears 911 extending from major portion 
912. The first step in this example manufacturing procedure is 
carried out by micro-fabrication of metal parts. For example, 
a 5"x5" sheet of metal may be used in conjunction with 
various techniques such as photo chemical milling, photo-
definition, etching, laser-cutting, stamping, or the like, to 
fabricate the microelectrode 510 shown in FIG. 9A. Dotted 
line 905 represents an axis along which major portion 912 
may be folded with respect to the pair of ears 911 as described 
below using FIG. 9B. 
FIG. 9B shows microelectrode 510 viewed after comple-
tion of a second step in the example manufacturing procedure 
of microelectrode 510 in accordance with an embodiment of 
the present invention. The second step involves bending 
microelectrode 510 along dotted line 905 shown in FIG. 9A. 
The bending may be carried out using a suitable micro-press 
or other arrangement. In terms of dimensions, a height 915 of 
microelectrode 510 may be selected in accordance with vari-
ous implementations. For example, in a first example imple-
mentation, height 915 is about 1 µm, while in a second imple-
mentation, height 915 is about 5 mm. Width dimensions may 
also be selected in accordance with various implementations. 
For example, in a first example implementation, width 920 is 
greater than width 925, but less than width 935. In a second 
example implementation, width 920 is greaterthan width 925 
as well as width 935. In a third example implementation, 
width 925 is less than width 920 as well as width 935. 
The flat-bottom configuration of major portion 912 after 
the bending procedure permits microelectrode 510 to be 
placed in an upright position embedded in the cPDMS mate-
rial. When so embedded in the in the cPDMS material, the 
longitudinal portion and the insertable tip of microelectrode 
510 can flex in at least two directions without detaching 
microelectrode 510 from the cPDMS material. 
It will be understood, that in contrast to microelectrode 510 
(described above with reference to FIGS. 9A and 9B), which 
is fabricated from a metal sheet, in an alternative embodi-
ment, microelectrode 510 may be a micromachined stainless 
steel microneedle or an electrochemically milled stainless 
steel microneedle. An illustrative example of a stainless steel 
microneedle 1000 is shown in FIG. 10. The stainless steel 
microneedle 1000 may have a minimum sharpness of a 
pointed tip 1005 that is less than or equal to about 1 µm and a 
diameter of a longitudinal portion 1010 in the order of a few 
micrometers. Base portion 1015, may have various shapes, 
including circular, oval, square, rectangular, or the like, and 
may also include various protruding portions (not shown) 
such as fingers and ears extending out from a central major 
portion. In the example embodiment shown in FIG. 10, stain-
less steel microneedle 1000 has a tapered insertion tip with no 
trailing edges. However, in other embodiments, stainless steel 
microneedle 1000 may have an arrowhead tip shape that 
includes leading and trailing edges and/or tapered leading and 
US 9,248,273 B2 
9 
trailing slopes. In another embodiment of the present inven-
tion, the microneedle is constructed of a material other than 
stainless steel. 
FIG. 11 shows 3D microelectrode device 500 configured 
for coupling to an extender assembly 900 using a lamination 
process. Extender assembly 900 may include a rigid substrate 
such as in a printed circuit board (PCB) extender assembly or 
may include a flexible substrate such as in a Kapton extender 
assembly. For convenience of description, extender assembly 
900 shown in FIG. 11 will be interpreted as a flexible Kapton 10 
assembly and will be described below accordingly. However, 
one of ordinary skill in the art will understand how this 
description may be applied to a PCB assembly as well. 
10 
chemical bonding process having two portions: a mechanical 
portion that brings the components together and holds them in 
place due to pressure being applied to the parts, and a chemi-
cal portion that is achieved due to the activation of both 
surfaces in oxygen plasma prior to the bonding. These two 
portions cooperatively bring the two surfaces with conductive 
materials (gold on Kapton and metal flakes in cPDMS) in 
contact with each other at a nanometer scale level (in contrast 
to various conventional meal-to-metal bonding processes.) 
The chemical portion of the bonding constitutes an oxygen 
free radical bonding to another oxygen free radical as a result 
of excess free radicals being created during the oxygen 
plasma activation of the surfaces. An X-Ray Photoelectron 
Spectroscopy (XPS) study of the two surfaces provides an The set of cPDMS pads 530 is a part of3D microelectrode 
device 500, while a corresponding set of metal pads 1125 is a 
part of PCB assembly 900. The cPDMS-pad-to-metal-pad 
contact is established by a lamination process that is 
described below in more detail. In particular, flex circuit 
based lamination provides desirable advantages in terms of 
stretchability and compatibility for connecting to electronic 
circuitry. 
15 insight into the chemical nature of the bonding. As is known 
in the art, XPS is an analytical technique wherein a mono-
chromatic beam of x-rays is directed into a sample in order to 
and detect the characteristics of electrons that are ejected 
from the sample. The energies and the number of electrons 
The set of metal tracks (including metal track 1135) as well 
as the set of metal pads 1125 on extender assembly 900 may 
be provided using standard computer-aided-design (CAD) 
processes for defining the tracks on the Kapton substrate 
1130, followed by additive processes (lift-off techniques, for 
example) or subtractive processes (metal etching, for 
example). 
20 can be used to study not only the elements present on the 
sample surface but also their abundance and their chemical 
bonding state as well. Since the technique is highly surface 
sensitive (information at-5 nm from the top of the surface can 
be gleaned from an XPS study), it can detect elements at very 
25 low concentrations. The XPS results are summarized in Table 
In one example implementation using additive definition, a 
photoresist layer of about 6 µm is spin coated onto a Kapton 30 
substrate 1130 (of about 12.5 µmin thickness) that is immo-
bilized on a glass wafer (used as a carrier). The photoresist 
layer is exposed using UV lithography (for example, I line 
with 365 nm wavelength and 1150 mJ/cm2 dose) and the 
pattern is then developed to define the metal tracks on the 
Kapton substrate 1130. 
35 
After a short de-scum process to remove resist residue 
utilizing oxygen plasma (using a Reactive Ion Etch tool, for 
example), a metal stack ( 50 nm of Ti or Cr and 500 nm of Au, 
for example) is evaporated using a directional deposition tool 
(such as an E-Beam Evaporator). After the evaporation the 
photoresist is lifted off the Kap ton substrate 113 0 using a soak 
in an acetone bath leaving behind the metal track patterns. 
Lamination of the 3D microelectrode device 500 and the 
extender assembly 900, more particularly, set of cPDMS pads 
530 and the corresponding set of metal pads 1125 may be 
carried out as described below. Metal pads 1125 may be 
formed of any suitable metal, such as, for example, gold, 
copper, or metal compounds. The same laminating procedure 
may be used to attach a connector 1140 to Kapton substrate 
1130. 
The surfaces of Kapton substrate 1130 and flexible sub-
strate 505 are treated to a 1 minute oxygen plasma cycle prior 
40 
45 
50 
55 
to the lamination. This process activates the surfaces and 
improves the adhesion between the two substrates. A lamina-
tion stack, as shown in FIG. 12, is then prepared. An interme-
diate acrylic adhesive layer (12.5 µm thick) may be utilized to 
bind the two substrates together. The lamination may be per-
formed at a temperature of about 275° F. and a pressure of 
about 750 psi. The acrylic adhesive reflows at such tempera- 60 
tures and binds the two materials involved. 
The lamination bonding process creates a mechanical/ 
chemical bond to bring together cPDMS/PDMS/Kapton and 
metal (gold, for example) in an intimate contact mode that 
provides mechanical integrity as well as electrical conductiv- 65 
ity without the use of solder or epoxy adhesives. This lami-
nation bonding process may be interpreted as a mechanical/ 
1 shown below, which demonstrates an increase in oxygen 
content on all surfaces prior and post treatment of the surface 
using oxygen plasma. An increase in gold content on the 
Kapton surface and an increase in silicon content on the 
cPDMS surface are also observable from the results. 
TABLE 1 
XPS Results 
Material Composition Native Material Oxygen Plasma Treated 
cPDMS 
Carbon(%) 46 27 
Oxygen(%) 28 41 
Silicon(%) 25 30 
Otber Elements (%) 2 
PDMS 
Carbon(%) 44 24 
Oxygen(%) 26 48 
Silicon(%) 29 27 
Otber Elements (%) 
Au/Kaplan 
Carbon(%) 62 28 
Oxygen(%) 19 19 
Gold(%) 19 53 
Otber Elements (%) 0 0 
Kaplan 
Carbon(%) 69 61 
Oxygen(%) 20 30 
Otber Elements (%) 11 9 
FIG. 12 shows a lamination apparatus 1200 for executing a 
lamination process to form a cPDMS-element-to-metal-ele-
ment contact in accordance with an embodiment of the 
present invention. More particularly, lamination apparatus 
1200 shown in FIG. 12 may be used for forming an electri-
cally-conductive contact between the set of cPDMS pads 530 
of3D microelectrode device 500 and the corresponding set of 
metal pads 1125 of extender assembly 900. 
Lamination apparatus 1200 has a sandwich structure that 
includes a pair of aluminum blocks 1205 and 1245, a first pair 
ofrelease layers 1210and1240, a pairof padding layers 1215 
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and 1235, and a second pair of release layers 1220 and 1230. 
Each of the release layers may be selected of a material such 
as Teflon, so as to prevent adjacent layers from attaching to 
one another. 
12 
approximately 160° C. for about 15 minutes in order to cure 
the cPDMS material, while ensuring that the base portion of 
each of the microneedles is completely encased inside 
cPDMS. 
Padding layer 1215 includes an opening 1216 and has a 5 
thickness "hl" while release layer 1220 includes an opening 
1217 and has a thickness "h2." 3D microelectrode device 500 
In step 1330, a layer of PDMS 19 is spun-coated on the 
upper surface of the sub-assembly such that the PDMS layer 
19 covers the cPDMS material. In one example implementa-
tion, the PDMS layer 19 is about 300 µm thick. is located between release layer 1220 and release layer 1230 
such that microelectrode 510, which is an upright microelec-
trode having a height "h3," is aligned with the openings 1216 
and 1217. Thicknesses "hl" and "h2 are selected to exceed 
"h3" and the size of openings 1216 and 1217 are selected to 
accommodate microelectrode 510 without touching the sides 
of openings 1216 and 1217 when microelectrode 510 is 
inserted into these openings during the lamination process. It 
will be understood that multiple openings may be provided 
when multiple microelectrodes are present in 3D microelec-
trode device 500. 
Lamination apparatus 1200 allows execution of a compres-
sion procedure on the set of cPDMS pads 530 of 3D micro-
electrode device 500 and the corresponding set of metal pads 
1125 of extender assembly 900 without adversely impacting 
microelectrode 510 (and other such microelectrodes). 
FIG.13 illustrates an SU-8 based procedure for fabricating 
a 3D microelectrode device in accordance with an embodi-
ment of the present invention. In step 1305, a silicon wafer 12 
is cleaned using piranha and Buffered Oxide Etch (BOE) 
solutions, followed by rinsing using deionized water. A layer 
ofSU-8material11 is then spin coated upon the silicon wafer 
12. In one example implementation, the SU-8 layer 11 is 
about 100 µm thick. The SU-8 layer 11 is then soft-baked to 
evaporate any solvent that may be present. 
In step 1310, metal trace patterns (such as, for example, the 
tracks and pads of 3D microelectrode device 500 shown in 
FIG. 5), are provided in the SU-8 layer 11. This may be 
carried out by first generating a template using tools such as 
CAD and a high-resolution printer, followed by transferring 
the pattern from the template to the SU-8layer11 using UV 
photolithography (for example, using I line with 365 nm 
wavelength and 600 mJ/cm2 dose). The pattern in the SU-8 
layer 11 is then developed to form an SU-8 micromold. The 
SU-8 micromold includes areas 23 that correspond to a track 
or a pad in the finished product. As can be understood, track 
widths of around 1 µm, or even smaller, may be fabricated by 
using such a procedure. 
In step 1315, a metal layer 15 is deposited on the SU-8 
micromold using a sputter coater. Various types of metals 
and/or metal compounds such as chromium (Cr), titanium 
(Ti) and gold (Au), individually or in combination, may be 
used. In one example implementation, a combination of 50 
nm of Cr and 500 nm of Au is used. The metal layer is 
operative as a separation layer during a demolding step later 
in the process. Additionally, a non-silicone mold release layer 
may be spray coated on to the SU-8 micromold. 
The PDMS layer is then cured using an oven, for example. 
10 After the PDMS layer 19 is cured, the SU-8 micromold is 
detached as indicated in step 1335, and may be re-used for 
fabricating additional 3D microelectrode devices. 
In step 1340, additional PDMS 19 is used to encapsulate 
the cPDMS pads and traces shown in step 1335. The resulting 
15 assembly constitutes the completed 3D microelectrode 
device 400. 
The process described above, allows fabrication of various 
parts of 3D microelectrode device 400 down to miniature 
sizes in comparison to conventional processes that incorpo-
20 rate steps such as PCB patterning, etching, soldering and/or 
epoxy attachments of microelectrodes. The dimension of the 
cPDMS tracks fabricated by way of the process described 
above, may be characterized by a minimum width of around 
1 µm. In one example implementation, the overall size of the 
25 3D microelectrode device is about 7 .5mmxl1.5 mm, with the 
microelectrodes having a diameter of about 37 µm with 425 
µm spacing in a 4x4 grid arrangement. 
FIG.14 illustrates a silicon-based procedure for fabricating 
a 3D microelectrode device in accordance with an embodi-
30 ment of the present invention. A silicon wafer 22 of a suitable 
dimension, for example, having a thickness of about 550 µm 
and 4 inch2 to 6 inch2 area, is provided. In step 1405, silicon 
wafer 22 is cleaned with piranha followed by a deionized 
water rinse. This is followed by cleaning with buffered hydro-
35 chloric acid and a deionized water rinse. A negative or posi-
tive photoresist layer 21 is then spin coated upon silicon wafer 
22 to a thickness of about 6 µm. 
In step 1410, metal trace patterns (such as, for example, the 
tracks and pads of 3D microelectrode device 500 shown in 
40 FIG. 5), are provided in the photoresist layer 21. This may be 
carried out by first generating a template using tools such as 
CAD and a high-resolution printer, followed by transferring 
the pattern from the template to the photoresist layer 21 using 
UV photolithography (for example, using I line with 365 nm 
45 wavelength and 1150 mJ/cm2 dose). The pattern in the pho-
toresist layer 21 is then developed to form a micromold. The 
micromold includes areas 13 that correspond to a track or a 
pad in the finished product. 
In step 1415, the exposed silicon regions 23 are etched 
50 using a deep reactive ion etch (DRIE) process. The etching 
process is controlled such the sidewalls are smooth and 
almost perpendicular to a depth of about 100 µm. After the 
etching process, photoresist layer 21 is removed with solvents 
or by utilizing a piranha clean. 
In step 1320, cPDMS 18 (which is prepared as described 55 
below), is cast into the SU-8 micromold utilizing processes 
such as, for example, screen printing or squeegeeing. Air 
bubbles may then be removed using a suitable vacuuming 
operation. Upon completion of step 1325, the cPDMS tracks 
and pads of the 3D microelectrode device have been defined. 60 
Steps 1420, 1425, 1430, 1435, 1440and1445 are substan-
tially similar to steps 1320, 1325, 1330, 1335, 1340and1345 
described above with reference to FIG. 13. 
Formulation of the cPDMS used in the fabrication pro-
cesses described above (with reference to FI GS. 13 and 14 for 
example) will now be described in more detail. PDMS mate-
rial (such as Sylgard 184™) and a curing agent are pre-mixed In step 1325, a microneedle (such as microneedle 510) is 
placed in a respective pad location (pad 515, for example) 
such that the base portion of microneedle 510 is encased in 
cPDMS 18. The placement may be carried out manually or by 
using a pick-and-place machine for placing multiple micron- 65 
eedles in multiple pad locations. After placement of the one or 
more microneedles, the sub-assembly is placed in an oven at 
together at a 10:1 ratio. Silver particles are then combined 
with the pre-mixed PDMS at a 4: 1 ratio, for example, to create 
a cPDMS mixture. Various other ratios may be selected on the 
basis of achieving a desired level of electrical conductivity 
along with a desired level of stretchability. The high tempera-
ture of the curing process described above with reference to 
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FIGS. 13and14, reduces the volume of the cPDMS mixture 
by about 20%, thereby bringing the silver particles into 
greater contact with each other and further reducing the resis-
tance of the heat-treated material. 
In summary, this disclosure describes various embodi-
ments of a 3D microelectrode device that can be used for live 
tissue applications. The disclosure further describes a few 
example methods of fabricating such a 3D microelectrode 
device. The device, which includes a flexible substrate con-
taining poly-dimethyl siloxane (PDMS), may be fabricated in 10 
14 
or tissue when the leading portion of the arrowhead tip has 
penetrated the outer surface of the organ, muscle, or tissue. 
5. The device according to claim 3, wherein the trailing 
portion of the arrowhead tip is configured to be oriented at an 
angle to the outer surface of the organ, muscle, or tissue when 
the leading portion of the arrowhead tip has penetrated the 
outer surface of the organ, muscle, or tissue, the angle 
selected to provide a hindering action when the arrowhead tip 
is withdrawn through the outer surface of the organ, muscle, 
or tissue. 
6. The device according to claim 1, wherein the microelec-
trode is a stainless steel microneedle and the flexible substrate 
comprises poly-dimethyl siloxane (PDMS) material. 
7. The device according to claim 6, wherein the stainless 
steel microneedle is one of a laser micromachined stainless 
steel microneedle or a electrochemically-milled stainless 
steel microneedle having a minimum sharpness that is less 
than or equal to about 1 µm, and wherein a minimum width of 
a miniature form factor suitable for attachment to a small 
organ such as a lateral gastrocnemius muscle of a live rat. In 
addition to providing a miniaturized, conformable attach-
ment, the device provides an anchoring action via one or more 
microelectrodes, each having an insertable tip particularly 15 
shaped to provide the anchoring action. Furthermore, a base 
portion of each of the microelectrodes is embedded inside 
conductive poly-dimethyl siloxane ( cPDMS). The cPDMS is 
contained in a pad that is coupled to a conductive track 
embedded in the flexible substrate. Embedding of the base 
portion inside the cPDMS material not only allows the micro-
electrode to bend in various directions, but also provides good 
electrical conductivity while eliminating the need for attach-
ment processes using solder or epoxy adhesives. 
20 the track is about 1 µm. 
8. The device according to claim 6, wherein the flexible 
substrate, the track, and the stainless steel microneedle are 
included in an implantable package configured to be inserted 
under the tissue surface. 
9. The device according to claim 8, wherein the flexible 
substrate included in the implantable package is selected for 
placement of the implantable package on at least one of a 
kidney or a brain of a rat. 
Persons of ordinary skill in the art will appreciate that 25 
though the devices and methods in accordance with the 
embodiments of the present invention have been described by 
means of specific embodiments and applications thereof, it is 
understood that numerous modifications and variations could 10. The device according to claim 8, wherein the flexible 
30 substrate included in the implantable package is selected for 
placement of the implantable package on a lateral gastrocne-
mius muscle of a rat. 
be made thereto without departing from the spirit and scope of 
the disclosure. 
11. The device according to claim 6, wherein the implant-
able device is configured to interface with a device for con-
35 taining and testing cells in-vitro. 
Accordingly, it is to be understood that the inventive con-
cept is not to be limited by the specific illustrated embodi-
ments, but only by the scope of the appended claims. The 
description may provide examples of similar features as are 
recited in the claims, but it should not be assumed that such 
similar features are identical to those in the claims unless such 
identity is essential to comprehend the scope of the claim. In 
some instances the intended distinction between claim fea-
tures and description features is underscored by using slightly 40 
different terminology. 
12. The device according to claim 1, further comprising: 
a plurality of signal-conducting tracks embedded in the 
flexible substrate, each of the plurality of tracks com-
prising conductive poly-dimethyl siloxane (cPDMS) 
material; and 
a plurality of microelectrodes arranged in an array configu-
ration, each of the plurality of microelectrodes compris-
ing a base portion and a protruding portion, the base 
portion having a shape configured for anchoring the 
microelectrode in the cPDMS material, and the protrud-
ing portion having a shape configured for penetrating the 
The invention claimed is: 
1. An implantable device comprising: 
a flexible substrate configured to provide three-dimen- 45 
sional conformance with a live organ, muscle, or tissue 
susceptible to movement; outer surface of the organ, muscle, or tissue and for 
anchoring the implantable device in the organ, muscle, 
or tissue. 
at least one track embedded in the flexible substrate for 
conducting an electrical signal, the track comprising 
conductive poly-dimethyl siloxane (cPDMS) material; 50 
and 
13. The device according to claim 12, wherein the base 
portion comprises a substantially planar surface oriented 
orthogonal to a longitudinal axis of the protruding portion. 
14. The device according to claim 13, wherein the protrud-
ing portion comprises a longitudinal shaft having the base 
55 portion located at one end and a pointed tip located at an 
opposing end. 
at least one microelectrode comprising a base portion, a 
longitudinal portion, and an insertable tip, the base por-
tion having a shape configured for anchoring the base 
portion in the cPDMS material, and the insertable tip 
having a leading portion configured for penetrating an 
outer surface of the organ, muscle, or tissue. 
2. The device according to claim 1, wherein the insertable 
tip has a trailing portion having a shape configured for 
anchoring the microelectrode to the organ, muscle, or tissue. 
3. The device according to claim 2, wherein the insertable 
tip is an arrowhead tip located at one end of the longitudinal 
portion, and the base portion is located at an opposing end of 
the longitudinal portion. 
4. The device according to claim 3, wherein the trailing 
portion of the arrowhead tip is configured to be oriented 
substantially parallel to the outer surface of the organ, muscle, 
15. The device according to claim 14, wherein the longi-
tudinal shaft has at least one of a circular, a rectangular, or a 
square cross-section, and wherein the pointed tip is an arrow-
60 head tip. 
16. The device according to claim 15, wherein the arrow-
head tip includes at least one tapered corner for anchoring the 
arrowhead tip to the organ, muscle, or tissue. 
17. The device according to claim 16, wherein each of the 
65 plurality of microelectrodes is one of a laser micromachined 
stainless steel microneedle or a electrochemically-milled 
stainless steel microneedle having a minimum sharpness of 
US 9,248,273 B2 
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less than or equal to about 1 µm and wherein the flexible 
substrate comprises poly-dimethyl siloxane (PDMS) mate-
rial. 
18. The device according to claim 12, wherein the array 
configuration is at least a 2x2 array of microelectrodes 5 
arranged in an area of about 2 mm2 , with an inter-electrode 
spacing of about 200 µm. 
* * * * * 
16 
